About
Inhalon Biopharma is a clinical-stage biotechnology company developing inhaled antibody treatments for acute respiratory infections including RSV, hMPV, influenza, and SARS-CoV-2 to enable effective at-home treatment.
Explore Inhalon Biopharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.